Curapath, formerly Polypeptide Therapeutic Solutions S.L. (PTS), is a company specialized in the custom synthesis of well-defined polypeptides and is the only global provider capable of offering exact PGA chain lengths with low molecular weight distributions and batch-to-batch consistency for R&D in the pharmaceutical, cosmetic, and biotech industries.
CEO
Robert Shaw
WEBSITE
https://curapath.com/
EXITED COMPANY
2016–2021 (Acquired by Arcline Investment Management)
DETAILS
Polypeptide Therapeutic Solutions S.L.
Av. Benjamin Franklin 19
46980 Paterna, Valencia (Spain).
